Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_assertion type Assertion NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_head.
- NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_assertion wasGeneratedBy ECO_0000203 NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_provenance.
- NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_assertion wasDerivedFrom befree-20140225 NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_provenance.
- NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_assertion SIO_000772 22914439 NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_provenance.
- NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_assertion evidence source_evidence_literature NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_provenance.
- NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_assertion description "[Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252624.RAocWlwikAI-O7TCvG7aM4PDLDBJ4-OrNDrN8Jgsi8vm8130_provenance.